IST:ECILC

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. · IST · Healthcare · TRY · FY for 2025

Figures on this page computed 2026-11-08 12:25 UTC

Last close

n/aTRY

Market data

16.2xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
TRY
- computed
- Computed from the filing for 2025
-0.5%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
21.2%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
19.1%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.05Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
4.0%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
TRY
- computed

What it pays out is the furthest below its sector's middle: 0.44 against 0.44 on the market's range.

All from 100

lens 2 of 9

Sales

699

2016-12-31 to 2025-12-31100 at the start699

Sales: 100.00 on 2016-12-31 to 698.76 on 2025-12-31, up 599%.

Profit

1,130

2016-12-31 to 2025-12-31100 at the start1,130

Profit: 100.00 on 2016-12-31 to 1130.27 on 2025-12-31, up 1030%.

Shares in issue

101

2016-12-31 to 2025-12-31100 at the start101

Shares in issue: 100.00 on 2016-12-31 to 101.45 on 2025-12-31, up 1%.

Sales is at 699, Profit is at 1130, Shares in issue is at 102, against 100 in 2016.

Sales is at 699, Profit is at 1130, Shares in issue is at 102, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100699
Source
computed
Statement
income
Fiscal year
2025
Reported in
TRY
Profit, where the first year is 1001,130
Source
computed
Statement
income
Fiscal year
2025
Reported in
TRY
Shares in issue, where the first year is 100102
Source
computed
Statement
income
Fiscal year
2025
Reported in
TRY